References
1. Lin TM, Halbert SP, Spellacy WN. Measurement of pregnancy-associated plasma proteins during human gestation. J Clin Invest. 1974 Sep;54(3):576-82.
2. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early preg-nancy levels of pregpreg-nancy-associated plasma protein a and the risk of intrauterine growth re-striction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002 Apr;87(4):1762-7.
3. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. Circulating human preg-nancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem. 1993 Jun 15;268(17):12243-6.
4. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screen-ing for Down's syndrome. Prenat Diagn. 1997 Sep;17(9):821-9.
5. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Di-agn. 2007 Mar;27(3):264-71.
6. Marttala J, Peuhkurinen S, Laitinen P, Gissler M, Nieminen P, Ryynanen M. Low maternal PAPP-A is associated with small-for-gestational age newborns and stillbirths. Acta Obstet Gynecol Scand. 2010 Sep;89(9):1226-8.
7. Yliniemi A, Makikallio K, Korpimaki T, Kouru H, Marttala J, Ryynanen M. Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia. Clinical medicine insights.Reproductive health. 2015;9:13.
8. Kaijomaa M, Rahkonen L, Ulander V, Hämäläinen E, Alfthan H, Markkanen H, et al. Low maternal pregnancy‐associated plasma protein A during the first trimester of pregnancy and pregnancy outcomes. International Journal of Gynecology & Obstetrics. 2017;136(1):76-82.
9. Lambert-Messerlian G, Eklund EE, Chien EK, Rosene-Montella K, Neveux LM, Haddow HR, et al. Use of first or second trimester serum markers, or both, to predict preeclampsia.
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health.
2014;4(4):271-8.
10. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predic-tors of pregnancy complications. BJOG: An International Journal of Obstetrics & Gynaecol-ogy. 2000;107(10):1265-70.
11. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr‐Urtreger A. Decreased first trimester PAPP‐A is a predictor of adverse pregnancy outcome. Prenatal Diagnosis: Published in Affil-iation With the International Society for Prenatal Diagnosis. 2002;22(9):778-82.
12. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First-tri-mester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concen-trations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Obstet Gynecol. 2004;191(4):1446-51.
13. Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, et al.
Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler and PAPP‐
A at 11–14 weeks' gestation. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2007;29(2):135-40.
14. Patil M, Panchanadikar TM, Wagh G. Variation of papp-a level in the first trimester of pregnancy and its clinical outcome. J Obstet Gynaecol India. 2014 Apr;64(2):116-9.
15. Handschuh K, Guibourdenche J, Guesnon M, Laurendeau I, Evain-Brion D, Fournier T.
Modulation of PAPP-A expression by PPARgamma in human first trimester trophoblast. Pla-centa. 2006 Apr;27 Suppl A:127.
16. Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, et al. Lo-calization of pregnancy-associated plasma protein-A and coloLo-calization of pregnancy-associ-ated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest. 1994 Oct;71(4):560-6.
17. Overgaard MT, Oxvig C, Christiansen M, Lawrence JB, Conover CA, Gleich GJ, et al.
Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tis-sues. Biol Reprod. 1999 Oct;61(4):1083-9.
18. Conover CA. Key questions and answers about pregnancy-associated plasma protein-A.
Trends Endocrinol Metab. 2012 May;23(5):242-9.
19. Robbins JR, FAU SK, FAU ZV, Kapidzic M FAU - Bakardjiev, Anna,I., Bakardjiev AI.
Placental syncytiotrophoblast constitutes a major barrier to vertical transmission of Listeria monocytogenes. PLoS pathogens JID - 101238921. 309 0.
20. Tuuri T, Sainio K. Alkion varhaisvaiheet ja naisen sukupuolielinten kehitys. In: Tapanai-nen J, Heikinheimo O, Mäkikallio K, editors. Naistentaudit ja synnytykset. Kustannus Oy Duodecim; 2019.
21. Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstetrics and gynecology international. 2014;2014.
22. Erkkola, Risto. "Pre-eklampsia On Istukkasairaus." Duodecim : Lääketieteellinen Aika-kauskirja 114, no. 21 (1998): 2237-2242.
23. Cohen P. Overview of the IGF-I system. Hormone research JID - 0366126. 2006.
24. Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. Role of the IGF system in tropho-blast invasion and pre-eclampsia. Hum Reprod. 1999 Dec;14 Suppl 2:90-6.
25. Hiden U, Glitzner E, Hartmann M, Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J Anat. 2009 Jul;215(1):60-8.
26. Kadakia R, Josefson J. The Relationship of Insulin-Like Growth Factor 2 to Fetal Growth and Adiposity. Horm Res Paediatr. 2016 Jan 27;85(2).
27. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3149-53.
28. Oxvig C. The role of PAPP-A in the IGF system: location, location, location. J Cell Com-mun Signal. 2015 Jun;9(2):177-87.
29. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer EM, et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development. 2004 Mar;131(5):1187-94.
30. Ning Y, Schuller AG, Conover CA, Pintar JE. Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol Endocrinol.
2008 May;22(5):1213-25.
31. Smith GC, Shah I, Crossley JA, Aitken DA, Pell JP, Nelson SM, et al. Pregnancy-associ-ated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Ob-stet Gynecol. 2006 Jan;107(1):161-6.
32. Monget P, Oxvig C. PAPP-A and the IGF system. Ann Endocrinol (Paris). 2016 Jun;77(2):90-6.
33. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, et al.
IGF-I is required for normal embryonic growth in mice. Genes Dev. 1993 Dec;7(12B):2609-17.
34. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozy-gous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990 May 3;345(6270):78-80.
35. Dubova EA, Pavlov KA, Lyapin VM, Kulikova GV, Shchyogolev AI, Sukhikh GT. Ex-pression of insulin-like growth factors in the placenta in preeclampsia. Bull Exp Biol Med.
2014 May;157(1):103-7.
36. Fialova L, Malbohan IM. Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects. Bratisl Lek Listy. 2002;103(6):194-205.
37. Sikiön kehityshäiriöiden seulonta, ensimmäinen trimesteri [Internet].; 2019 [cited 28.4.2019]. Available from:
http://webohjekirja.mylabservices.fi/ISLAB/in-dex.php?test=4548.
38. Wright D, Silva M, Papadopoulos S, Wright A, Nicolaides KH. Serum pregnancy-associ-ated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015 Apr 2.
39. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. First-trimester screening mark-ers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol. 2009 Jan;33(1):8-17.
40. Autti-Rämö I, Koskinen H, Mäkelä M, Ritvanen A, Taipale P. Raskauden ajan ultraääni-tutkimukset ja seerumiseulonnat rakenne- ja kromosomipoikkeavuuksien tunnistamisessa.
http://urn.fi/URN:NBN:fi-fe201204194014: Stakes, FinOHTA; 2005.
41. Savvidou MD, Syngelaki A, Muhaisen M, Emelyanenko E, Nicolaides KH. First tri-mester maternal serum free ?-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus. BJOG: An International Journal of Obstetrics & Gynaecology. 2012;119(4):410-6.
42. Pandya P, Wright D, Syngelaki A, Akolekar R, Nicolaides KH. Maternal serum placental growth factor in prospective screening for aneuploidies at 8-13 weeks' gestation. Fetal Diagn Ther. 2012;31(2):87-93.
43. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol.
2008 May;31(5):493-502.
44. Spencer K, Cowans NJ. Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dos-age. Prenatal diagnosis JID - 8106540. 2013.
45. Illescas T, Fernandez C, Ortega D, de la Puente M, Coronado P, Montalvo J. Influence of gravidity and foetal gender on the value of screening variables in the first trimester of preg-nancy. Eur J Obstet Gynecol Reprod Biol. 2013 Mar;167(1):14-7.
46. Huynh L, Kingdom J, Akhtar S. Low pregnancy-associated plasma protein A level in the first trimester. Can Fam Physician. 2014 Oct;60(10):899-903.
47. Sikiöseulonnat [Internet].; 2006. Available from: https://stm.fi/seulonnat/sikioseulonnat.
48. Lau GW, Feldman DS, Morales CM, Smith D, Edwards R, Williams J,3rd. First-trimester aneuploidy screening: is there a maternal age at which it loses effectiveness? J Reprod Med.
2014;59(9-10):443-7.
49. Wright D, Syngelaki A, Bradbury I, Akolekar R, Nicolaides KH. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing. Fetal Diagn Ther.
2014;35(2):118-26.
50. Määttä T, Wilska M. Downin oireyhtymä. Lääkärin käsikirja. Kustannus Oy Duodecim;
2018.
51. Ghidini A, Gratacos E. Can prenatal screening reduce the adverse obstetric outcomes re-lated to abnormal placentation? Prenat Diagn. 2014 Jul;34(7):613-7.
52. Salomon C, Yee SW, Mitchell MD, Rice GE. The possible role of extravillous tropho-blast-derived exosomes on the uterine spiral arterial remodeling under both normal and pathological conditions. BioMed research international JID - 101600173. 2014.
53. Roman A, Desai N, Krantz D, Liu HP, Rosner J, Vohra N, et al. Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction. Prenat Diagn.
2014 Jul;34(7):692-8.
54. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-74.
55. Herraiz I, Lopez-Jimenez EA, Garcia-Burguillo A, Nieto O, Villar OP, Escribano D, et al.
Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation. Ultrasound Obstet Gynecol. 2009 May;33(5):518-23.
56. Smith GC, Crossley JA, Aitken DA, Pell JP, Cameron AD, Connor JM, et al. First-tri-mester placentation and the risk of antepartum stillbirth. JAMA. 2004 Nov 10;292(18):2249-54.
57. Blumenfeld YJ, Baer RJ, Druzin ML, El-Sayed YY, Lyell DJ, Faucett AM, et al. Associ-ation between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption. Am J Obstet Gynecol. 2014 Aug;211(2):144.e9.
58. Desai N, Krantz D, Roman A, Fleischer A, Boulis S, Rochelson B. Elevated first tri-mester PAPP--a is associated with increased risk of placenta accreta. Prenat Diagn. 2014 Feb;34(2):159-62.
59. Thompson O, Otigbah C, Nnochiri A, Sumithran E, Spencer K. First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placenta-tion. BJOG. 2015 Feb 2.
60. Heino A, Vuori E, Kiuru S, Gissler M. Perinataalitilasto – synnyttäjät, synnytykset ja vastasyntyneet 2017
http://www.julkari.fi/bitstream/han-dle/10024/137072/Tr38_18.pdf?sequence=5&isAllowed=y: Terveyden ja hyvinvoinnin lai-tos; .
61. Raatikainen K, Huurinainen P, Heinonen S. Smoking in early gestation or through preg-nancy: a decision crucial to pregnancy outcome. Prev Med. 2007;44(1):59-63.
62. Saari A, Sankilampi U, Hannila M, Kiviniemi V, Kesseli K, Dunkel L. New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med. 2011;43(3):235-48.
63. Erkkola R. Sikiön kasvun hidastuminen
. In: Ylikorkala O, Tapanainen J, editors. Naistentaudit ja synnytykset. Kustannus Oy Duode-cim; 2011. p. 448-56.
64. Suomalaisen Lääkäriseuran Duodecimin ja Suomen Gynekologiyhdistyksen asettama työ-ryhmä. Ennenaikainen synnytys. Saatavilla internetissä: www.kaypahoito.fi. 2019 Suomalai-nen Lääkäriseura Duodecim, 2018 (Viitattu 30.4.2019).
65. Goetzinger KR, Cahill AG, Macones GA, Odibo AO. Association of first-trimester low PAPP-A levels with preterm birth. Prenat Diagn. 2010 Apr;30(4):309-13.
66. Kirkegaard I, Uldbjerg N, Petersen OB, Torring N, Henriksen TB. PAPP-A, free beta-hCG, and early fetal growth identify two pathways leading to preterm delivery. Prenat Diagn.
2010 Oct;30(10):956-63.
67. Saruhan Z, Ozekinci M, Simsek M, Mendilcioglu I. Association of first trimester low PAPP-A levels with adverse pregnancy outcomes. Clin Exp Obstet Gynecol. 2012;39(2):225-8.
68. Ulander VM, Mentula M, Nikander E. Keskenmeno. In: Tapanainen J, Heikinheimo O, Mäkikallio K, editors. Naistentaudit ja synnytykset. Kustannus Oy Duodecim; 2019.
69. Ruge S, Pedersen JF, Sorensen S, Lange AP. Can pregnancy-associated plasma protein A (PAPP-A) predict the outcome of pregnancy in women with threatened abortion and con-firmed fetal viability? Acta Obstet Gynecol Scand. 1990;69(7-8):589-95.
70. Hanita O, Roslina O, Azlin MI. Maternal level of pregnancy-associated plasma protein A as a predictor of pregnancy failure in threatened abortion. Malays J Pathol. 2012
Dec;34(2):145-51.
71. Zhang Y, Zhao Q, Xie Y, Su K, Yang J, Yang L. A correlation analysis between the ex-pression of pregnancy-associated plasma protein A in basal decidual cells and recurrent spon-taneous abortion. Exp Ther Med. 2013 Aug;6(2):485-8.
72. van Ravenswaaij R, Tesselaar-van der Goot M, de Wolf S, van Leeuwen-Spruijt M, Visser GH, Schielen PC. First-trimester serum PAPP-A and fbeta-hCG concentrations and other maternal characteristics to establish logistic regression-based predictive rules for ad-verse pregnancy outcome. Prenat Diagn. 2011 Jan;31(1):50-7.
73. Hustin J, Jauniaux E, Schaaps JP. Histological study of the materno-embryonic interface in spontaneous abortion. Placenta. 1990;11(6):477-86.
74. Alberman ED, Creasy MR. Frequency of chromosomal abnormalities in miscarriages and perinatal deaths. J Med Genet. 1977;14(5):313-5.
75. Lehtonen T, Tikkanen M, Laine J. Tupakointi raskauden aikana voi johtaa sikiökuole-maan ja istukan ennenaikaiseen irtoamiseen. Duodecim 2017;133:524–6.
76. D'Souza R, Shah PS. Predicting stillbirths–still a distant reality. BJOG: An International Journal of Obstetrics & Gynaecology. 2015;122(1):56.
77. Tiitinen A. Kohtukuolema (sikiökuolema). In: Lääkärikirja Duodecim. ; 2018.
78. Ekholm E, Laivuori H. Pre-eklampsia ja muu raskaudenaikainen verenpaineen nousu . In: Ylikorkala O, Tapanainen J, editors. Naistentaudit ja synnytykset. Kustannus Oy Duode-cim; 2011. p. 413-21.
79. Raio L, Bolla D, Baumann M. Hypertension in pregnancy. Curr Opin Cardiol. 2015 Jul;30(4):411-5.
80. von Dadelszen P, Magee LA. Pre-eclampsia: an update. Curr Hypertens Rep. 2014 Aug;16(8):8.
81. Allen RE, Rogozinska E, Cleverly K, Aquilina J, Thangaratinam S. Abnormal blood bi-omarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:194-201.
82. Roberts JM, Bell MJ. If we know so much about preeclampsia, why haven't we cured the disease? J Reprod Immunol. 2013 Sep;99(1-2):1-9.
83. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010 Aug 21;376(9741):631-44.
84. Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation. Ultrasound Obstet Gynecol. 2018;52(2):186-95.
85. Karahasanovic A, Sorensen S, Nilas L. First trimester pregnancy-associated plasma pro-tein A and human chorionic gonadotropin-beta in early and late pre-eclampsia. Clin Chem Lab Med. 2014 Apr;52(4):521-5.
86. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐
trimester uterine artery Doppler. Prenatal Diagnosis: Published in Affiliation With the Inter-national Society for Prenatal Diagnosis. 2005;25(10):949-53.
87. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐ec-lampsia. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2007;29(2):128-34.
88. Sahraravand M, Jarvela IY, Laitinen P, Tekay AH, Ryynanen M. The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of preg-nancy. Placenta. 2011 Dec;32(12):999-1003.
89. Ismail KI, Hannigan A, O’Donoghue K, Cotter A. Abnormal placental cord insertion and adverse pregnancy outcomes: a systematic review and meta-analysis. Systematic reviews.
2017;6(1):242.
90. Ranta JK, Raatikainen K, Romppanen J, Pulkki K, Heinonen S. Decreased PAPP-A is as-sociated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2011;157(1):48-52.